• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.73% Nasdaq Down2.63%

    Daxor Corp. (DXR)

    8.02 Up 0.14(1.75%) 10:56AM EDT - Nasdaq Real Time Price
    ProfileGet Profile for:
    Daxor Corp.
    Empire State Building
    Suite 7120
    New York, NY 10118
    United States - Map
    Phone: 212-330-8500
    Fax: 212-244-0806
    Website: http://www.daxor.com

    Index Membership:N/A
    Industry:Medical Instruments & Supplies
    Full Time Employees:N/A

    Business Summary 

    Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Daxor Corp.

    Key Executives 
    Dr. Joseph Feldschuh M.D., 81
    Chairman, Chief Exec. Officer, Pres, Chief Scientific Officer and Director of Lab Services (Leave of Absence)
    Mr. Michael Richard Feldschuh , 47
    Acting Chief Exec. Officer, Acting Pres and Director
    Mr. Eric P. Coleman ,
    Chief Financial Officer
    Richard Dunn ,
    Director of Operations
    Ms. Lisa Quartley ,
    First Sr. VP of Marketing and Commercial Devel.
    Amounts are as of Dec 31, 2015 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders